Andrew Chantry

Royal Hallamshire Hospital — United Kingdom

Medicine · Health Sciences

23h-index2.5kcitations95works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(42), Bone health and treatments(26), Peptidase Inhibition and Analysis(11), Cancer Treatment and Pharmacology(8), Blood donation and transfusion practices(7)

Publications93 total

Double hit ultra-high risk myeloma treated with isatuximab, bortezomib, lenalidomide, dexamethasone and cyclophosphamide (Isa-VRDc) induction and isa-VRD consolidation: Initial results of the UK myeloma research alliance (UKMRA)  RADAR trial in newly diagnosed transplant eligible patients
Blood·2025
An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy
Leukemia·2025· 2 citedOpen Access
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease
JBMR Plus·2024· 4 citedOpen Access
Outcomes of percutaneous vertebroplasty in multiple myeloma: a tertiary neurosciences experience with long-term follow-up
Frontiers in Oncology·2024· 4 citedOpen Access
Disrupted biographies and gendered identities: A qualitative study exploring sexuality and blood cancer
European Journal of Oncology Nursing·2024
Health-Related Quality of Life (HRQoL) in Patients with Genetic Standard and High-Risk Disease at Trial Entry: A Cross-Sectional Analysis of RADAR (UK-MRA Myeloma XV)
Blood·2023· 1 cited
High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra RADAR Study
Blood·2023· 1 cited
RADAR Trial: MRD Response Adapted Trial for Newly Diagnosed Transplant Eligible Myeloma Patients
Blood·2023· 2 cited
Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human
Journal of Neuroscience·2023· 15 citedOpen Access
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
Blood Advances·2023· 12 citedOpen Access
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
Viruses·2023· 4 citedOpen Access
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Journal for ImmunoTherapy of Cancer·2023· 19 citedOpen Access
Metastatic infiltration of nervous tissue and periosteal nerve sprouting in multiple myeloma induced bone pain
2022Open Access
Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation
Blood·2022· 7 cited
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
BMJ Open·2022· 15 citedOpen Access
P-133: Myeloma-induced bone pain: lessons learnt from a localized, immunocompetent mouse model
Clinical Lymphoma Myeloma & Leukemia·2022
What Can Patient Narratives Reveal to Us About the Experience of a Diagnosis of Myeloma? A Qualitative Scoping Review
Journal of Patient Experience·2022· 8 citedOpen Access
The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
Cancers·2021· 8 citedOpen Access
Assessment of Minimal/Measurable Residual Disease Testing in Acute Myeloid Leukaemia By Molecular Methods in an Interlaboratory Study
Blood·2021
Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo
Blood·2021· 1 cited
page 1 of 5Next →

Frequent Co-authors

Michelle A. Lawson(16), Holly Evans(12), John A. Snowden(10), Peter I. Croucher(6), Karin Vanderkerken(5), Julia Paton‐Hough(5), Darren Lath(5), Kwee Yong(5), Guy Pratt(4), Karthik Ramasamy(4), Kenneth S. Charles(4), Matthew Streetly(3), Neil Rabin(3), Jenny Down(3), Alanna C. Green(3), Mark T. Drayson(3), Stuart Scott(3), Liam Whitby(3), Gordon Cook(3), Graham Jackson(3)